LPS abolishes extrasplenic vasoconstriction to atrial natriuretic peptide: The role of NO and endothelin 1

Shock

Volumn 29, Issue 6, 2008, Pages 675-680

  Mansart, Arnaud ^a   Ross, Jonathan J ^a   Reilly, Charles S ^a   Brown, Nicola J ^a   Brookes, Zoë L S ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Atrial natriuretic peptide; Endothelin 1; NO; Sepsis; Spleen; Veins

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BOSENTAN; ENDOTHELIN 1; LIPOPOLYSACCHARIDE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; DOSE RESPONSE; MALE; MESENTERIC VEIN; MYOGRAPHY; NONHUMAN; RAT; SPLEEN; VASOCONSTRICTION;

EID: 44449141297     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31815811a3     Document Type: Article

References (40)

1. Andrew PS, Deng Y, Kaufman S: Fluid extravasation from spleen reduces blood volume in endotoxemia. Am J Physiol 28:R60-R65, 2000.
2. Gardiner SM, Kemp PA, March JE, Bennett T: Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br J Pharmacol 116:2005-2016, 1995.
3. Hall E, Brookes ZL: Angiopoietin-1 increases arteriolar vasoconstriction to phenylephrine during sepsis. Regul Pept 131:34-37, 2005.
4. Gunnett CA, Lund DD, Faraci FM, Heistad DD: Vascular interleukin-10 protects against LPS-induced vasomotor dysfunction. Am J Physiol Heart Circ Physiol 289:H624-H630, 2005.
5. Andersson R, Bengmark S: Influence of splenectomy, partial splenectomy and splenic artery ligation on E. coli sepsis in rats. Acta Chir Scand 155:451-454, 1989.
6. Chien S, Chang C, Dellenback RJ, Usami S, Gregersen MI: Hemodynamic changes in endotoxin shock. Am J Physiol 210:1401-1410, 1966.
7. Qu XW, Rozenfeld RA, Huang W, Crawford SE, Gonzalez-Crussi F, Hsueh W: Interaction of platelet-activating factor, spleen and atrial natriuretic peptide in plasma volume regulation during endotoxaemia in rats. J Physiol 512:227-234, 1998.
8. Chen A, Kaufman S: Splenic blood flow and fluid efflux from the intravascular space in the rat. J Physiol 490:493-499, 1996.
9. Kaufman S, Deng Y: Splenic control of intravascular volume in the rat. J Physiol 468:557-565, 1993.
10. Endlich K, Steinhausen M: Natriuretic peptide receptors mediate different responses in rat renal microvessels. Kidney Int 52:202-207, 1997.
11. Andrew PS, Kaufman S: Guanylyl cyclase mediates ANP-induced vasoconstriction of murine splenic vessels. Am J Physiol 284:R1567-R1571, 2003.
12. Brookes ZL, Kaufman S: Myogenic responses and compliance of mesenteric and splenic vasculature in the rat. Am J Physiol Regul Integr Comp Physiol 284:R1604-R1610, 2003.
13. Sultanian R, Deng Y, Kaufman S: Atrial natriuretic factor increases splenic microvascular pressure and fluid extravasation in the rat. J Physiol 533:273-280, 2001.
14. Brookes ZL, Kaufman S: Effects of atrial natiuretic peptide (ANP) on the extra-splenic microvasculature and lymphatics in the rat in vivo. J Physiol 565:269-277, 2005.
15. Deng Y, Kaufman S: Influence of atrial natriuretic factor on fluid efflux from the splenic circulation of the rat. J Physiol 491:225-230, 1996.
16. Reilly FD: Innervation and vascular pharmacodynamics of the mammalian spleen. Experientia 41:187-192, 1985.
17. Ueda S, Nishio K, Akai Y, Fukushima H, Ueyama T, Kawai Y, Masui K, Yoshioka A, Okuchi K: Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock. Shock 26:134-139, 2006.
18. Mitaka C, Nagura T, Sakanishi N, Tsunoda Y, Toyooka H: Plasma alpha-atrial natriuretic peptide concentrations in acute respiratory failure associated with sepsis: preliminary study. Crit Care Med 18:1201-1203, 1990.
19. Wang C, Mansard A, Giummelly P, Atkinson J: Decreased aortic smooth muscle contraction in a rat model of multibacterial sepsis. Fundam Clin Pharmacol 18:679-683, 2004.
20. Piepot HA, Groeneveld AB, van Lambalgen AA, Sipkema P: Endotoxin impairs endothelium-dependent vasodilation more in the coronary and renal arteries than in other arteries of the rat. J Surg Res 110:413-418, 2003.
21. Vo PA, Lad B, Tomlinson JA, Francis S, Ahluwalia A: Auto regulatory role of endothelium-derived nitric oxide (NO) on lipopolysaccharide-induced vascular inducible NO synthase expression and function. J Biol Chem 280:7236-7243, 2005.
22. Giusti-Paiva A, Martinez MR, Felix JV, da Rocha MJ, Carnio EC, Elias LL, Antunes-Rodrigues J: Simvastatin decreases nitric oxide overproduction and reverts the impaired vascular responsiveness induced by endotoxic shock in rats. Shock 21:271-275, 2004.
23. Wanecek M, Weitzberg E, Rudehill A, Oldner A: The endothelin system in septic and endotoxin shock. Eur J Pharmacol 407:1-15, 2000.
24. Sugiura M, Inagami T, Kon V: Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 161:1220-1227, 1989.
25. de Nucci G, Thomas R, D'Orleans-Juste P, Antunes E, Walder C, Warner TD, Vane JR: Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A 85:9797-9800, 1998.
26. Andrew PS, Deng Y, Sultanian R, Kaufman S: Nitric oxide increases fluid extravasation from the splenic circulation of the rat. Am J Physiol Regul Integr Comp Physiol 280:R959-R967, 2001.
27. Mindham MA, Mayes PA: The fuel of the spleen. Studies using a new method for perfusing the rat spleen with whole blood. Biochem J 263:325-332, 1989.
28. Balmer P, Phillips HM, Maestre AE, McMonagle FA, Phillips RS: The effect of nitric oxide on the growth of Plasmodium falciparum, P. chabaudi and P. berghei in vitro. Parasite Immunol 22:97-106, 2000.
29. Papapetropoulos A, Marczin N, Catravas JD: Cross-tolerance between endogenous nitric oxide and exogenous nitric oxide donors. Eur J Pharmacol 344:313-321, 1998.
30. Chabot F, Mitchell JA, Quinlan GJ, Evans TW: Characterization of the vasodilator properties of peroxynitrite on rat pulmonary artery: role of poly (adenosine 5′-diphosphoribose) synthase. Br J Pharmacol 121:485-490, 1997.
31. Scott JA, Mehta S, Duggan M, Bihari A, McCormack DG: Functional inhibition of constitutive nitric oxide synthase in a rat model of sepsis. Am J Respir Crit Care Med 165:1426-1432, 2002.
32. Wort SJ, Evans TW: The role of the endothelium in modulating vascular control in sepsis and related conditions. Br Med Bull 55:30-48, 1999.
33. Schwartz D, Mendonca M, Schwartz I, Xia Y, Satriano J, Wilson CB, Blantz RC: Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J Clin Invest 100:439-448, 1997.
34. Murad F, Rapoport RM, Fiscus R: Role of cyclic-GMP in relaxations of vascular smooth muscle. J Cardiovasc Pharmacol 7:S111-S118, 1985.
35. Han B, Hasin Y: Cardiovascular effects of natriuretic peptides and their interrelation with endothelin-1. Cardiovasc Drugs Ther 17:41-52, 2003.
36. Forni M, Mazzola S, Ribeiro LA, Pirrone F, Zannoni A, Bernardini C, Bacci ML, Albertini M: Expression of endothelin-1 system in a pig model of endotoxic shock. Regul Pept 131:89-96, 2005.
37. Oldner A, Wanecek M, Weitzberg E, Sundin P, Sollevi A, Rubio C, Hellstrom PM, Alving K, Rudehill A: Differentiated effects on splanchnic homeostasis by selective and non-selective endothelin receptor antagonism in porcine endotoxaemia. Br J Pharmacol 127:1793-1804, 1999.
38. Wanecek M, Oldner A, Sundin P, Alving K, Weitzberg E, Rudehill A: Effects on haemodynamics by selective endothelin ET(B) receptor and combined endothelin ET(A)/ET(B) receptor antagonism during endotoxin shock. Eur J Pharmacol 386:235-245, 1999.
39. Hirata Y, Ishimaru S: Effects of endothelin receptor antagonists on endothelin-1 and inducible nitric oxide synthase genes in a rat endotoxic shock model. Clin Sci 103:332S-335S, 2002.
40. Madhani M, Scotland RS, MacAllister RJ, Hobbs AJ: Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. Br J Pharmacol 139:1289-1296, 2003.